Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC
Holger Hebart
Michael Kiehl
Jiri Tomasek
Tibor Csoszi
Reija Koukakis
George Kafatos
Anja Kuhn
Katja Bjorklof
Gaston Demonty
Tomas Buchler
10.6084/m9.figshare.7571084.v1
https://adisjournals.figshare.com/articles/figure/Prospective_Observational_Cohort_Study_to_Describe_the_Use_of_Panitumumab_in_Combination_with_Chemotherapy_in_Real-World_Clinical_Practice_for_Patients_with_Wild-Type_RAS_mCRC/7571084
<p>Full copyright for enhanced digital
features is owned by <b>Amgen.</b></p><p><b><br></b></p>
<p> </p>
<p></p><p><strong>Article full
text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-019-0874-6"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional enhanced
digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides<u></u></p>
<p> </p><br><p></p>
2019-01-24 16:44:57
Metastatic colorectal cancer
Observational study
panitumumab
RAS wild-type
Real-world data
Tumor location